TipRanks
Perfect Medical Health Management Limited (HK:1830)
:1830
Hong Kong Market
Want to see HK:1830 full AI Analyst Report?

Perfect Medical Health Management Limited (1830) Ratios

11 Followers

Perfect Medical Health Management Limited Ratios

HK:1830's free cash flow for Q4 2025 was HK$0.48. For the 2025 fiscal year, HK:1830's free cash flow was decreased by HK$ and operating cash flow was HK$0.22. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.06 1.06 1.18 1.35 1.44
Quick Ratio
1.04 1.04 1.15 1.34 1.44
Cash Ratio
0.44 0.44 0.62 1.10 0.86
Solvency Ratio
0.63 0.74 0.69 0.71 0.79
Operating Cash Flow Ratio
1.01 1.01 0.83 0.96 1.08
Short-Term Operating Cash Flow Coverage
5.82 5.82 0.00 0.00 0.00
Net Current Asset Value
HK$ -90.61MHK$ -90.61MHK$ -85.57MHK$ -27.86MHK$ 68.27M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.16 0.23 0.22 0.19
Debt-to-Equity Ratio
0.35 0.35 0.57 0.54 0.39
Debt-to-Capital Ratio
0.26 0.26 0.36 0.35 0.28
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.15 2.15 2.46 2.46 2.12
Debt Service Coverage Ratio
4.26 5.08 35.73 46.65 41.25
Interest Coverage Ratio
27.27 27.21 22.71 34.07 29.45
Debt to Market Cap
0.04 0.04 0.00 0.00 0.00
Interest Debt Per Share
0.11 0.11 0.18 0.22 0.20
Net Debt to EBITDA
-0.04 -0.03 -0.07 -0.50 -0.35
Profitability Margins
Gross Profit Margin
55.91%47.22%63.77%65.41%47.69%
EBIT Margin
22.32%22.48%23.37%28.35%26.55%
EBITDA Margin
32.80%38.40%39.19%42.84%42.64%
Operating Profit Margin
22.52%22.48%22.31%27.44%26.55%
Pretax Profit Margin
21.94%21.94%22.39%27.54%28.18%
Net Profit Margin
18.57%18.57%18.34%22.66%22.72%
Continuous Operations Profit Margin
18.53%18.53%18.30%22.28%22.72%
Net Income Per EBT
84.63%84.63%81.92%82.30%80.63%
EBT Per EBIT
97.44%97.64%100.36%100.35%106.14%
Return on Assets (ROA)
21.42%21.42%22.11%25.85%24.35%
Return on Equity (ROE)
43.78%46.08%54.45%63.48%51.55%
Return on Capital Employed (ROCE)
43.47%43.38%46.89%54.24%47.56%
Return on Invested Capital (ROIC)
32.86%32.80%32.28%38.57%33.41%
Return on Tangible Assets
21.42%21.42%22.11%25.85%24.35%
Earnings Yield
12.06%12.70%7.26%8.03%6.40%
Efficiency Ratios
Receivables Turnover
29.84 29.84 35.41 22.01 27.60
Payables Turnover
179.80 215.21 474.62 450.44 867.14
Inventory Turnover
81.01 96.96 29.27 74.78 0.00
Fixed Asset Turnover
4.75 4.75 3.56 3.38 3.39
Asset Turnover
1.15 1.15 1.21 1.14 1.07
Working Capital Turnover Ratio
11.11 20.82 8.93 6.77 12.82
Cash Conversion Cycle
14.71 14.30 22.01 20.65 12.80
Days of Sales Outstanding
12.23 12.23 10.31 16.58 13.22
Days of Inventory Outstanding
4.51 3.76 12.47 4.88 0.00
Days of Payables Outstanding
2.03 1.70 0.77 0.81 0.42
Operating Cycle
16.74 16.00 22.78 21.46 13.22
Cash Flow Ratios
Operating Cash Flow Per Share
0.27 0.27 0.26 0.40 0.45
Free Cash Flow Per Share
0.25 0.25 0.24 0.35 0.43
CapEx Per Share
0.02 0.02 0.03 0.04 0.02
Free Cash Flow to Operating Cash Flow
0.91 0.91 0.90 0.90 0.95
Dividend Paid and CapEx Coverage Ratio
1.77 1.77 0.85 1.11 2.57
Capital Expenditure Coverage Ratio
11.22 11.22 9.61 9.18 20.96
Operating Cash Flow Coverage Ratio
2.52 2.52 1.54 1.85 2.33
Operating Cash Flow to Sales Ratio
0.35 0.35 0.30 0.36 0.40
Free Cash Flow Yield
20.86%21.98%10.46%11.33%10.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.29 8.00 14.19 12.45 15.63
Price-to-Sales (P/S) Ratio
1.54 1.46 2.53 2.82 3.55
Price-to-Book (P/B) Ratio
3.82 3.63 7.51 7.90 8.06
Price-to-Free Cash Flow (P/FCF) Ratio
4.79 4.55 9.56 8.83 9.24
Price-to-Operating Cash Flow Ratio
4.37 4.14 8.57 7.91 8.80
Price-to-Earnings Growth (PEG) Ratio
-0.66 -0.64 -0.39 0.00 0.00
Enterprise Value Multiple
4.66 3.77 6.38 6.09 7.98
Enterprise Value
1.47B 1.39B 2.82B 3.63B 4.73B
EV to EBITDA
4.66 3.77 6.38 6.09 7.98
EV to Sales
1.53 1.45 2.50 2.61 3.40
EV to Free Cash Flow
4.75 4.51 9.45 8.16 8.86
EV to Operating Cash Flow
4.33 4.11 8.47 7.31 8.43
Tangible Book Value Per Share
0.31 0.31 0.30 0.40 0.49
Shareholders’ Equity Per Share
0.31 0.31 0.30 0.40 0.49
Tax and Other Ratios
Effective Tax Rate
0.16 0.16 0.18 0.19 0.19
Revenue Per Share
0.77 0.77 0.90 1.11 1.11
Net Income Per Share
0.14 0.14 0.16 0.25 0.25
Tax Burden
0.85 0.85 0.82 0.82 0.81
Interest Burden
0.98 0.98 0.96 0.97 1.06
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.19 0.25 0.14 0.02 0.02
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.61 1.61 1.32 1.57 1.78
Currency in HKD